You are on page 1of 60

all fig.

in crore (Rs)

2006 2007
PAT 12.73 12.77
DEP 7.92 8.62
NWC 92.65 96.89 104.42
INWC 4.24 7.53
CAPEX 20.40 21.35

FCF -4.00 -7.48

growth rates
return on equity 0.1850
retention ratio 50%
g for next 5 years
after 2013 9.25%
g thereafter 5.00%

wacc calculation
cost of debt
cost of equity
interest paid 16.7 re
avg debt (2010) 177.64
cost of debt 0.094 rf
tax rate 28% rm
after tax cost of
debt 0.068 beta
re

equity capital
wacc 0.1198
ROE

ROE = net income/total stockholders’ equity =


Profit margin x Asset turnover x Equity multiplier
2008 2009 2010 2011E 2012E 2013E
13.07 15.05 26.1 38.37 46.00 54.81
9.63 11.04 13.52 15.62 18.04 20.83
102.99 96.91 110.42 110.42 110.42 110.42
-1.43 -6.08 13.51 0.00 0.00 0.00
33.53 21.38 21.38 30.00 35.00 45.00

-9.39 10.79 4.73 23.98 29.04 30.65


Terminal value
4.73 23.58 31.93 41.45
DISCOUNT FACTOR 1.00 0.89 0.80 0.71
PV 4.73 21.06 25.46 29.52

firm value 531.07


debt 177.64
total equity value 353.43
no of share holders 1.21
price per share 291.88
actual market price 142.96
SO STOCK IS UNDERVALUED
SENSITIVITY MATRIX( pric
discount rate

growth rate
2.50%
3%

3.50%
4%
4.50%
rf+ beta*(rm-rf) 5%
5.50%
interest on 10 yr givt. Bond 7.50%
avg stock market return over 10 yr
period 19%
0.96
18.54%

141.09
ASSSET EQUITY
PROFIT MARGIN TURNOVER MULTIPLIER
ity multiplier PAT SALES ASSETS
SALES ASSESTS EQUITY
0.053 1.56 2.26

ROE 0.18
2014E 2015E 2016E 2017E 2018E

33.48 36.58 39.96 43.66 47.69


717.51
49.74 59.69 71.62 85.95 765.20
0.64 0.57 0.51 0.45 0.40
31.63 33.90 36.33 38.93 309.51

NSITIVITY MATRIX( price / share )


9% 9.50% 10% 11% 12.00% 13%

owth rate
371.90 336.30 305.33 254.03 213.20 179.88
397.98 357.95 323.51 267.20 223.04 187.41

428.80 383.21 344.48 282.12 234.03 195.73


465.78 413.06 368.94 299.18 246.40 204.97
510.99 448.88 397.86 318.86 260.42 215.30
567.50 492.66 432.55 341.83 276.44 226.93
640.15 547.39 474.90 368.97 294.92 240.10
Industry - Pharmaceuticals - Indian - Bulk Drugs
[Rs. in Crs.]

   Year Latest 2010


No. of Companies 129 14
  INCOME :
  Sales Turnover 16,166.59 8,638.27
  Excise Duty 404.01 120.4
  Net Sales 15,762.58 8,517.87
  Other Income 1,646.78 1,225.54
  Stock Adjustments 252.2 -151.91
  Total Income 17,661.56 9,591.50
  EXPENDITURE :
  Raw Materials 8,108.35 3,925.31
  Power & Fuel Cost 596.53 393.75
  Employee Cost 1,178.19 805.44
  Other Manufacturing Expenses 1,290.10 433.69
  Selling and Administration Expenses 1,791.72 1,177.96
  Miscellaneous Expenses 851.13 354.4
  Less: Pre-operative Expenses Capitalised 1.3 0
  Total Expenditure 13,814.72 7,090.55
  Operating Profit 3,846.84 2,500.95
  Interest 872.25 442.78
  Gross Profit 2,974.59 2,058.17
  Depreciation 661.26 394.22
  Profit Before Tax 2,313.33 1,663.95
  Tax 318.86 166.34
  Fringe Benefit tax 12.34 0
  Deferred Tax 125 98.07
  Reported Net Profit 1,857.13 1,399.54
  Extraordinary Items 999.48 889.19
  Adjusted Net Profit 857.65 510.35
  Adjst. below Net Profit 7.26 2.44
  P & L Balance brought forward 2,852.39 1,874.21
  Statutory Appropriations 0 0
  Appropriations 1,216.71 869.38
  P & L Balance carried down 3,500.07 2,406.81
  Dividend 566.59 318.91
  Preference Dividend 0 0
2009 2008 2007 2006
56 66 65 68

13,930.68 ### 9,762.44 8,050.73


385.09 437.65 368.74 317.46
13,545.59 12,192.90 9,393.70 7,733.27
403 528.7 867.55 306.87
543.51 362.05 403.66 181.77
14,492.10 ### ### 8,221.91

7,068.58 6,225.27 5,290.36 4,281.08


514.29 458.95 365.05 298.16
972.82 797.19 644.78 519.66
1,181.45 1,019.66 483.95 387.35
1,432.84 1,278.96 1,066.15 863.06
680.57 449.5 191.74 161.04
0 0 0 0
11,850.55 10,229.53 8,042.03 6,510.35
2,641.55 2,854.12 2,622.88 1,711.56
587.53 377.74 326.15 302.81
2,054.02 2,476.38 2,296.73 1,408.75
517.48 444.36 375.08 322.44
1,536.54 2,032.02 1,921.65 1,086.31
213.32 280.17 224.53 195.03
31.29 25.46 20.24 19.12
48.32 84.45 47.95 35.79
1,243.61 1,641.94 1,628.93 836.37
18.75 133.09 453.55 7.65
1,224.86 1,508.85 1,175.38 828.72
12.59 18.06 3.13 -5.13
3,149.95 2,302.96 1,190.62 804.35
0 0 0 0
819.93 904.7 592.03 450.03
3,586.22 3,058.26 2,230.65 1,185.56
412.91 340.63 143.23 111.36
0 0.47 0.75 0.27
PRODUCTION

Year Bulk Drugs( cr.)


Growth (%) EXPORT import
1985-86 416 10.3 33.36 208.13
1986-87 458 10.2 87.16 207.49
1987-88 480 4.6 139.71 234.13
1988-89 550 14.6 242.87 328.35
1989-90 640 16.4 350.5 425.64
1990-91 730 14.1 413.4 322.57
1991-92 900 23.3 722.6 458.51
1992-93 1150 27.8 856.6 508.39
1993-94 1320 14.8 1009.6 612.74
1994-95 1518 15 1260.7 811.43
1995-96 1822 20 1132.9 1,630.00
1996-97 2186 20 1664.5 1,705.00
1997-98 2623 20 2214.8 1,827.00
1998-99 3148 20 2870.4 1,918.00
1999-00 3777 20 3100 2,025.00
2000-01 4533 20 3720 2,265.00
2001-02 5439 20 4501 2,435.00
2002-03 6529 20 5401 2,617.00
2003-04 7729 20 6481 2,813.00
2004-05 9034 20 3,024.00
*These figures do not include production from unorganized sector, which is estimated at an additiona

expenditure on R&D
1983-84 40
1985-86 48 All Figures in Rs Crore
1986-87 50 Domestic Market Exports Imports
1990-91 60 2003 30365 12826 2865
1991-92 80 2004 32575 15213 2956
1992-93 95 2005 34128 17857 3139
1993-94 125 2006 39989 22216 4515
1994-95 140 2007 45367 24942 5867
1995-96 160 2008 50946 30760 6734
1996-97 185 2009 55454 38433 8552
1997-98 220
1998-99 260
1999-00 320
2000-01 370.00
2001-02 435.00
2002-03 672.00
2003-04* 1,054.00
2004-05* 1,686.00
Imports
Formulations(cr.)
Growth(%) total volume domestic Investment in Pharmaceutic
1945 6.5 2361
2140 10 2598 Year
2350 9.8 2830 1965
3150 12.5 3700 1973
3420 8.6 4060 1977
3840 12.3 4570 1979
4800 25 5700 1982
6000 25 7150 1985
6900 15 8220 1988
7935 15 9453 1993
9125 15 10947 1994
10494 15 12680 1995
12068 15 14691 1996
13878 15 17026 1997
15960 15 19737 1998
18354 15 22887 1999
21104 15 26543 2000
24185 15 30714 2001
27692 15 35421 2002
31946 15 40980 2003
estimated at an additional 35% of the production. 2004

Total Market Size


42326
47332
52029
62566
68442
78610
89335
estment in Pharmaceutical Industry
(Rs. In crores)
Amount
Annual Increase (%)
140 60.71
225 100
450 11.11
500 20
600 8.33
650 23.08
800 32.5
1,060 13.21
1,200 8.33
1,300 23.08
1,600 15
1,840 16.85
2,150 16.27
2,500 16
2,900 16
3,364 16
3,903 16
4,528 16
5,253 16
Company 1 Year 9 Month 6 Month 3 Month 1 Month

Aarey Drugs 44 46.35 34.65 23.25 26.3


-42.27% -45.20% -26.70% 9.25% -3.42%

Aarti Drugs 69.15 87 93.15 119.85 134.35


106.29% 63.97% 53.14% 19.02% 6.18%

Abbott India 561.3 789.85 890.05 1029.25 1128.3


101.57% 43.24% 27.12% 9.92% 0.27%

ABL Biotech 22.8 18.3 20.8 17.3 22.35


-17.32% 3.01% -9.37% 8.96% -15.66%

Advik Labors 4.02 3.88 4 4.15 5.47


46.02% 51.29% 46.75% 41.45% 7.31%

Ahlcon Parent 37.9 37.9 49.85 64.75 80.05


138.13% 138.13% 81.04% 39.38% 12.74%

Ajanta Pharma 88.95 97.4 151.65 188.95 219.85


166.61% 143.48% 56.38% 25.51% 7.87%

Albert David 84.35 121.35 116.35 125.3 126.05


53.94% 7.00% 11.60% 3.63% 3.01%

Alembic 47.25 45.1 45.75 45.9 56.85


26.14% 32.15% 30.27% 29.85% 4.84%

Alpa Laboratori 13.54 11.84 12.82 15.24 17.45


21.49% 38.94% 28.32% 7.94% -5.73%

Ambalal Sarabha 12.35 12.51 11.11 10.14 11.38


-13.12% -14.23% -3.42% 5.82% -5.71%

Amrutanjan Heal 378.15 435 575.6 791.9 741.45


82.73% 58.85% 20.05% -12.74% -6.80%

Ankur Drugs 155.15 200.3 195.1 176.25 172


-12.02% -31.85% -30.04% -22.55% -20.64%

Anuh Pharma 352.65 313.3 410.5 369.85 544.85


60.12% 80.23% 37.55% 52.67% 3.63%

Anus Labs 12.06 7.98 6.92 6.02 5.45


-55.89% -33.33% -23.12% -11.63% -2.39%
Arvind Remedies 1.83 1.82 1.89 1.83 1.86
12.57% 13.19% 8.99% 12.57% 10.75%

Astec Life 83.9 89.45 46.5 62.1 74.35


-7.15% -12.91% 67.53% 25.44% 4.77%

AstraZeneca 805.25 945.6 872.05 822 1224.8


49.12% 26.98% 37.69% 46.08% -1.96%

Auro Labs 2.87 4.14 3.3 4.51 3.8


78.40% 23.67% 55.15% 13.53% 34.74%

Aurobindo Pharm 704.45 863.25 922.15 834.15 980.6


48.61% 21.27% 13.53% 25.51% 6.76%

Aventis Pharma 1449.65 1548.2 1626.9 1850 1868.75


24.54% 16.61% 10.97% -2.41% -3.39%

Bafna Pharma 23.1 34.15 29 41.85 42.25


85.50% 25.48% 47.76% 2.39% 1.42%

Bal Pharma 24.35 27.1 25.75 26.25 29.6


21.15% 8.86% 14.56% 12.38% -0.34%

BDH Industries 12.87 15.15 14.51 22.95 28.25


73.27% 47.19% 53.69% -2.83% -21.06%

Beryl Drugs 11.18 6.61 10.29 18.25 31.95


204.56% 415.13% 230.90% 86.58% 6.57%

Bharat Immuno 18.65 20.25 19.05 17.85 21.4


21.98% 12.35% 19.42% 27.45% 6.31%

Biocon 230.65 267.3 269.05 287.8 312.9


48.78% 28.38% 27.54% 19.23% 9.67%

Biofil Chem 2.43 4.39 3.77 3.5 3.8


55.14% -14.12% - 7.71% -0.79%

Brawn Pharma 14.63 15.15 15.15 11.5 11.4


12.78% 8.91% 8.91% 43.48% 44.74%

Cadila Health 299.91 420.92 528.96 598.1 629.1


108.16% 48.32% 18.02% 4.38% -0.76%

Caplin Point La 7.35 8.39 8.46 12.41 17.05


89.12% 65.67% 64.30% 12.01% -18.48%
Celestial Labs 21.45 27 34.45 32.55 37
50.82% 19.81% -6.10% -0.61% -12.57%

Cipla 270.45 331.1 315.2 324.35 325.8


12.87% -7.81% -3.16% -5.89% -6.31%

Colinz Labs 4.8 4.31 4.93 5.73 7.2


53.75% 71.23% 49.70% 28.80% 2.50%

Coral Labs 47 61.45 59 78.15 134.05


137.02% 81.29% 88.81% 42.55% -16.90%

Country Condos 7.87 6.55 4.94 3.56 3.96


-50.95% -41.07% -21.86% 8.43% -2.53%

DIL 208.8 255.05 247 262.6 325.35


114.22% 75.38% 81.09% 70.34% 37.48%

Dishman Pharma 215.65 231.65 204.85 193.1 215.9


-10.36% -16.56% -5.64% 0.10% -10.47%

Divis Labs 513.5 635.7 632.5 749.3 756.7


45.07% 17.19% 17.78% -0.58% -1.55%

Dr Reddys Labs 779.85 1123.2 1135.6 1404.75 1351.25


76.74% 22.71% 21.37% -1.88% 2.00%

Elder Healthcar 37.6 62.15 74.4 83.05 91.1


169.95% 63.31% 36.42% 22.22% 11.42%

Elder Pharma 295.75 263.7 368.95 350.3 367.2


37.55% 54.27% 10.26% 16.13% 10.78%

FDC 46 64.25 75.6 95.8 86


135.65% 68.72% 43.39% 13.15% 26.05%

Fresenius Kabi 81.5 93.35 115.95 127.55 154.3


77.42% 54.90% 24.71% 13.37% -6.29%

Fulford 575.9 733.45 890.15 981.35 1091.8


78.23% 39.95% 15.31% 4.60% -5.99%

Gennex Labs 15.5 22.05 1.9 1.48 1.63


-90.39% -93.24% -21.58% 0.68% -8.59%

GlaxoSmithKline 1441.3 1663.5 1702.05 2105.85 2014.4


32.50% 14.80% 12.20% -9.31% -5.20%

Glenmark 219.45 251.05 255.95 266.05 270.25


31.94% 15.34% 13.13% 8.83% 7.14%

Godavari Drugs 5.48 6.3 5.2 7 7.99


36.13% 18.41% 43.46% 6.57% -6.63%

Granules India 79.05 90.75 94.85 96.1 90.75


18.34% 3.09% -1.37% -2.65% 3.09%

Gufic Bio 6.29 6.26 6.7 5.89 6.6


10.97% 11.50% 4.18% 18.51% 5.76%

Guj Terce Labs 5.88 18.3 15.55 10.45 14.75


122.79% -28.42% -15.76% 25.36% -11.19%

Guj Themis 6.12 8.5 10.28 12.55 10.2


83.66% 32.24% 9.34% -10.44% 10.20%

Hester Bio 86.45 98.5 117.25 129.25 143.5


79.29% 57.36% 32.20% 19.92% 8.01%

Hikal 340.6 410.1 362.35 357.75 388.55


26.91% 5.40% 19.29% 20.82% 11.25%

Hiran Orgochem 47.65 8.99 8.9 9.62 10.1


-78.97% 11.46% 12.58% 4.16% -0.79%

Ind-Swift 25.55 29.45 28.55 30.55 33.9


69.28% 46.86% 51.49% 41.57% 27.58%

Ind-Swift Labs 57.6 68.6 64.2 69.1 81.35


120.23% 84.91% 97.59% 83.57% 55.93%

Indoco Remedies 202.55 289.05 319.4 408.05 414.05


110.02% 47.17% 33.19% 4.25% 2.74%

Inwinex Pharma 3.09 5.38 43.8 31.5 28.15


754.37% 390.71% -39.73% -16.19% -6.22%

Ipca Labs 138 201.37 217.64 271.35 278.3


106.56% 41.56% 30.97% 5.05% 2.43%

Ishita Drugs 10.63 9.12 9.26 14.3 13.47


98.49% 131.36% 127.86% 47.55% 56.64%
Jagson Pharma 18.6 17.4 17.6 20.3 21.1
41.94% 51.72% 50.00% 30.05% 25.12%

JB Chemicals 48.9 50.7 67.1 78.3 98.8


118.00% 110.26% 58.87% 36.14% 7.89%

Jenburkt Pharma 32.9 37.5 49.95 71.35 79.25


135.71% 106.80% 55.26% 8.69% -2.15%

Jupiter Bio 76.95 79.7 80.95 82.65 89.4


39.51% 34.69% 32.61% 29.89% 20.08%

Kappac Pharma 7.5 7.87 22.8 42.15 48.65


670.67% 634.43% 153.51% 37.13% 18.81%

KDL Biotech 8.94 9.25 12.35 11.65 12.85


44.52% 39.68% 4.62% 10.90% 0.54%

Kerala Ayur 52.25 47.25 49.5 43.15 49.7


-1.53% 8.89% 3.94% 19.24% 3.52%

Kilitch Drugs 83.5 79.15 97.4 92.9 113.8


51.68% 60.01% 30.03% 36.33% 11.29%

Kopran 16.65 25.2 30.45 32.8 42


140.24% 58.73% 31.36% 21.95% -4.76%

Krebs Biochem 29.65 31 34.05 34.25 37.2


39.29% 33.23% 21.29% 20.58% 11.02%

Lactose India 6.7 8.6 11.5 22.15 16.9


152.24% 96.51% 46.96% -23.70% -

Lincoln Pharma 33.65 27.9 30.5 30.75 35.3


21.84% 46.95% 34.43% 33.33% 16.15%

Lupin 193.41 275.81 300.77 368.84 380.57


86.42% 30.72% 19.88% -2.25% -5.26%

Lyka Labs 24.75 31.7 28.4 28 29.1


21.82% -4.89% 6.16% 7.68% 3.61%

Makers Labs 17.95 17.4 35.05 47.8 49.4


140.95% 148.56% 23.40% -9.52% -12.45%

Mangalam Drugs 10.92 11.35 13.45 13.78 16.15


40.75% 35.42% 14.28% 11.54% -4.83%
Marksans Pharma 6.13 4.94 5.03 4.19 4.17
-36.70% -21.46% -22.86% -7.40% -6.95%

Medicamen Bio 17.3 21.5 34 27 30


70.23% 36.98% -13.38% 9.07% -1.83%

Merck 401.8 561.25 618 630.1 715.95


73.98% 24.55% 13.11% 10.94% -2.36%

Morepen Lab 8.29 8.93 7.97 7.53 7.13


-21.23% -26.88% -18.07% -13.28% -8.42%

Natco Pharma 101.9 111.95 123.55 168.8 194.1


158.78% 135.55% 113.44% 56.22% 35.86%

Natural Capsule 29.85 47.2 39.75 42 46.8


42.71% -9.75% 7.17% 1.43% -8.97%

Nectar Life 21.4 28.6 36.75 37.1 34.7


52.80% 14.34% -11.02% -11.86% -5.76%

Neuland Lab 135.9 116.9 99.25 88.25 96.2


-29.51% -18.05% -3.48% 8.56% -0.42%

NGL Fine Chem 13.5 16.1 19.05 16.35 23


55.93% 30.75% 10.50% 28.75% -8.48%

Novartis India 490.35 556 523.85 594.35 644.85


33.82% 18.02% 25.26% 10.41% 1.76%

Nutraplus Prod 9 8.43 17.45 16.85 16.11


105.56% 119.45% 6.02% 9.79% 14.84%

Orchid Chemical 119.2 199.9 165.9 143.25 188.9


56.71% -6.55% 12.60% 30.40% -1.11%

Ortin Labs 13.4 19 13.01 17 27.6


105.22% 44.74% 111.38% 61.76% -0.36%

Panacea Biotec 182.85 186.1 184.35 174.6 184.55


3.91% 2.10% 3.06% 8.82% 2.95%

Panchsheel Org 13.59 33.5 37 18.5 20.45


69.98% -31.04% -37.57% 24.86% 12.96%

Parabolic Drugs 64.8 64.8 64.8 64.8 54.3


-11.57% -11.57% -11.57% -11.57% 5.52%

Parenteral Drug 99.1 121.55 200.75 193.3 254.9


184.16% 131.67% 40.27% 45.68% 10.47%

Pfizer 815.45 962.35 930.1 1039.25 1164.45


33.20% 12.87% 16.78% 4.52% -6.72%

Pharmaids Pharm 3.15 3.5 3.9 4.14 4.08


37.14% 23.43% 10.77% 4.35% 5.88%

Piramal Health 325.15 414.5 419.5 514.9 485.5


55.56% 22.03% 20.57% -1.77% 4.18%

Piramal Life 79 79.65 81.7 131.95 151.7


87.47% 85.94% 81.27% 12.24% -2.37%

Plethico Pharma 283.4 342 396.15 391.3 391.8


40.33% 16.29% 0.39% 1.64% 1.51%

Poonam Pharma 1.7 1.54 1.62 1.86 3.47


105.29% 126.62% 115.43% 87.63% 0.58%

Protochem 1.55 1.44 1.29 1.2 1.07


-23.23% -17.36% -7.75% -0.83% 11.21%

Ranbaxy Labs 322.9 483.65 479.35 429.85 452.55


56.04% 4.18% 5.11% 17.22% 11.34%

Roopa Industrie 4.12 5.5 6.88 8.19 9.61


227.43% 145.27% 96.08% 64.71% 40.37%

RPG Life 43.8 63.95 73 70.05 97.4


128.20% 56.29% 36.92% 42.68% 2.62%

Rubra Medicamen 29.99 21.5 17.95 70.3 29.2


-35.31% -9.77% 8.08% -72.40% -33.56%

Saamya Biotech 7.03 6.25 8.96 8.7 10.09


27.88% 43.84% 0.33% 3.33% -10.90%

Samrat Pharma 9.49 10.52 13.93 16 17.35


106.01% 85.84% 40.34% 22.19% 12.68%

Sandu Pharma 10.7 14.04 13.89 14.2 15.95


40.00% 6.70% 7.85% 5.49% -6.08%
Sanjivani Paren 20.85 26.4 53.45 42.95 46.05
120.38% 74.05% -14.03% 6.98% -0.22%

Sequent Scienti 64.25 107.6 136.5 149.95 142.2


95.64% 16.82% -7.91% -16.17% -11.60%

Sharon Bio Medi 75.6 79.5 108.75 129.15 158.5


101.06% 91.19% 39.77% 17.69% -4.10%

Shasun Chemical 29.45 37.8 37.75 62.65 78.15


173.17% 112.83% 113.11% 28.41% 2.94%

Shilpa 154 197.4 243.65 299.7 338.95


120.36% 71.91% 39.28% 13.23% 0.12%

Smruthi Organic 60.95 79.05 94.9 101.1 141.25


156.85% 98.04% 64.96% 54.85% 10.83%

SMS Pharma 142.15 139.75 160.3 165.05 187.1


40.34% 42.75% 24.45% 20.87% 6.63%

Solvay Pharma 770.75 1411.4 2851.45 2430.45 2696.65


249.02% 90.60% -5.66% 10.68% -0.24%

SS Organics 3.83 6.28 5.7 4.05 3.55


89.30% 15.45% 27.19% 79.01% 104.23%

Sterling Bio 114.5 93.7 101.8 110.3 107.25


-6.68% 14.03% 4.96% -3.13% -0.37%

Stride Arcolab 162.5 214.35 310 353.95 445.5


163.88% 100.05% 38.32% 21.15% -3.75%

Sun Pharma 1190 1495.35 1549 1680.6 1772.55


45.84% 16.06% 12.04% 3.27% -2.09%

Sun Pharma Adv 69.3 84.55 86.5 89.3 99.15


35.86% 11.35% 8.84% 5.43% -5.04%

Surya Pharma 106.25 119.15 163.1 168.1 185.95


168.75% 139.66% 75.08% 69.87% 53.56%

Suven Life Scie 29.6 28.45 26.25 27.5 27.8


-4.90% -1.05% 7.24% 2.36% 1.26%

Syncom Formula 21.45 20.95 27.5 34.35 35.05


67.60% 71.60% 30.73% 4.66% 2.57%
Syncom Health 87.85 87.85 99.55 38.85 41.25
-56.00% -56.00% -61.18% -0.51% -6.30%

Themis Medicare 141.15 156.45 184.05 237.3 248.2


68.72% 52.22% 29.39% 0.36% -4.05%

Tonira Pharma 24.5 32.05 28.1 29.95 29.5


18.57% -9.36% 3.38% -3.01% -1.53%

Torrent Cables 119.1 131.55 115.5 112.4 122.25


2.81% -6.92% 6.02% 8.94% 0.16%

Torrent Pharma 264.4 397.55 450.05 564.55 556


103.37% 35.25% 19.48% -4.76% -3.29%

Transchem 15.1 16.6 11.87 16.85 13.5


-2.72% -11.51% 23.76% -12.82% 8.81%

Trimurthi Drugs 33.55 5.55 4.73 4.25 4.44


-87.66% -25.41% -12.47% -2.59% -6.76%

TTK Healthcare 179 241.05 279.5 340.05 391.3


125.25% 67.27% 44.26% 18.57% 3.04%

Twilight Litaka 49.15 51.3 80.55 104.9 172.25


258.49% 243.47% 118.75% 67.97% 2.29%

Unichem Labs 226.45 274.1 358.3 422.95 435.1


94.86% 60.98% 23.15% 4.33% 1.41%

Unjha Formula 4.9 4.54 4.37 4.61 5.47


-2.86% 4.85% 8.92% 3.25% -12.98%

Vardhman Lab 4 3.81 2.94 4.07 4.99


53.75% 61.42% 109.18% 51.11% 23.25%

Venkat Pharma 4.57 6.1 5.1 4.61 4.98


2.19% -23.44% -8.43% 1.30% -6.22%

Venmax Drugs 6.15 6.15 6.15 6.15 8.26


23.25% 23.25% 23.25% 23.25% -8.23%

Venus Remedies 281.5 211.55 232.15 261.35 268.85


6.87% 42.21% 29.59% 15.11% 11.90%

Vikram Thermo 19.15 17 17.35 20.1 26.15


27.15% 43.24% 40.35% 21.14% -6.88%

Vista Pharma 6.69 6.9 7.45 7.08 16.43


169.81% 161.59% 142.28% 154.94% 9.86%

Vivimed Labs 93.95 135.55 128 170.25 201.5


161.89% 81.52% 92.23% 44.52% 22.11%

Wanbury 75.8 70 71.75 78.8 81.9


7.65% 16.57% 13.73% 3.55% -0.37%

Welcure Drugs 2.9 2.7 2.77 2.96 3.11


8.62% 16.67% 13.72% 6.42% 1.29%

Wintac 24 22.85 32.15 34.2 31.25


19.79% 25.82% -10.58% -15.94% -8.00%

Wockhardt 157.45 177.05 141.9 131.3 144.55


43.00% 27.17% 58.67% 71.48% 55.76%

Wyeth 626.05 734.6 744.05 779.9 839.5


27.59% 8.73% 7.35% 2.42% -4.85%

Zandu Realty 6968.5 9918.1 4152.45 3033.25 3101.1


-55.50% -68.74% -25.33% 2.23% -0.01%

Zenith Health 0.73 0.73 1.23 1.27 1.21


83.56% 83.56% 8.94% 5.51% 10.74%

Zenotech Labs 105.9 115.45 115.05 113.5 93.05


-19.12% -25.81% -25.55% -24.54% -7.95%

Zyden Gentec 3.2 2.68 2.15 2.39 1.83


-28.13% -14.18% 6.98% -3.77% 25.68%
2 Week 1 Week Last Price

25.05 24.65 25.4


1.40% 3.04%

138 137.7 142.65


3.37% 3.59%

1155.75 1168.9 1,131.40


-2.11% -3.21%

20.95 18.7 18.85


-10.02% 0.80%

5.95 5.35 5.87


-1.34% 9.72%

88 96.4 90.25
2.56% -6.38%

203.95 226.15 237.15


16.28% 4.86%

129.85 133.75 129.85


- -2.92%

57.35 61.1 59.6


3.92% -2.45%

17.35 17 16.45
-5.19% -3.24%

11.6 11.04 10.73


-7.50% -2.81%

727.4 708.1 691


-5.00% -2.41%

123.35 137.4 136.5


10.66% -0.66%

555.65 574.85 564.65


1.62% -1.77%

5.18 5.47 5.32


2.70% -2.74%
2.03 2.07 2.06
1.48% -0.48%

72.85 73.95 77.9


6.93% 5.34%

1210.3 1231 1,200.75


-0.79% -2.46%

4.21 4.74 5.12


21.62% 8.02%

1007 1033.8 1,046.90


3.96% 1.27%

1834 1810.4 1,805.35


-1.56% -0.28%

45.1 44.35 42.85


-4.99% -3.38%

28.75 29.6 29.5


2.61% -0.34%

24.55 24.85 22.3


-9.16% -10.26%

33.45 34.3 34.05


1.79% -0.73%

24.85 22.9 22.75


-8.45% -0.66%

340.45 336.2 343.15


0.79% 2.07%

3.84 3.88 3.77


-1.82% -2.84%

14.18 14.6 16.5


16.36% 13.01%

625.95 622.65 624.3


-0.26% 0.26%

14.55 13.75 13.9


-4.47% 1.09%
33.7 32.4 32.35
-4.01% -0.15%

304.3 307.15 305.25


0.31% -0.62%

6.75 7.39 7.38


9.33% -0.14%

107.35 104.7 111.4


3.77% 6.40%

4.35 3.84 3.86


-11.26% 0.52%

437.35 421.7 447.3


2.28% 6.07%

203.2 197.5 193.3


-4.87% -2.13%

738.3 754.65 744.95


0.90% -1.29%

1338.95 1339.9 1,378.30


2.94% 2.87%

106.25 143.9 101.5


-4.47% -29.46%

402.85 406.75 406.8


0.98% 0.01%

82.85 94.45 108.4


30.84% 14.77%

148.5 151.1 144.6


-2.63% -4.30%

1045.65 1003.35 1,026.45


-1.84% 2.30%

1.62 1.54 1.49


-8.02% -3.25%

1944.4 1871.9 1,909.70


-1.78% 2.02%

268.2 284.9 289.55


7.96% 1.63%

8.07 7.5 7.46


-7.56% -0.53%

92.25 92 93.55
1.41% 1.68%

7.13 6.8 6.98


-2.10% 2.65%

14.2 14 13.1
-7.75% -6.43%

10.93 10.9 11.24


2.84% 3.12%

146.5 152.5 155


5.80% 1.64%

388.25 438.45 432.25


11.33% -1.41%

10.01 10 10.02
0.10% 0.20%

35.6 42.2 43.25


21.49% 2.49%

82 123.7 126.85
54.70% 2.55%

400.85 417.1 425.4


6.12% 1.99%

30.1 27 26.4
-12.29% -2.22%

274.45 287 285.05


3.86% -0.68%

19.52 21.61 21.1


8.09% -2.36%
23.9 26 26.4
10.46% 1.54%

101.35 107.85 106.6


5.18% -1.16%

76.1 79.1 77.55


1.91% -1.96%

102.35 105.15 107.35


4.89% 2.09%

68 58.75 57.8
-15.00% -1.62%

13.5 13.37 12.92


-4.30% -3.37%

52.35 52 51.45
-1.72% -1.06%

113.4 107.9 126.65


11.68% 17.38%

39.85 41.05 40
0.38% -2.56%

36.5 36.5 41.3


13.15% 13.15%

18.25 17.75 16.9


-7.40% -4.79%

36.75 40.35 41
11.56% 1.61%

360.55 373.6 360.55


- -3.49%

28.15 30.5 30.15


7.10% -1.15%

46.15 44.7 43.25


-6.28% -3.24%

16 15.9 15.37
-3.94% -3.33%
4 3.98 3.88
-3.00% -2.51%

30.4 30.95 29.45


-3.12% -4.85%

697.65 706.4 699.05


0.20% -1.04%

7.07 6.74 6.53


-7.64% -3.12%

189.6 233.95 263.7


39.08% 12.72%

43 43.75 42.6
-0.93% -2.63%

31.75 33.4 32.7


2.99% -2.10%

96 95.75 95.8
-0.21% 0.05%

22.35 22.35 21.05


-5.82% -5.82%

648.6 663.1 656.2


1.17% -1.04%

19.04 19.2 18.5


-2.84% -3.65%

195.9 192.35 186.8


-4.65% -2.89%

28 27.9 27.5
-1.79% -1.43%

184.15 188 190


3.18% 1.06%

19.95 21.8 23.1


15.79% 5.96%

57.95 55.1 57.3


-1.12% 3.99%

255.65 251.75 281.6


10.15% 11.86%

1152.65 1132.9 1,086.20


-5.76% -4.12%

4.28 3.75 4.32


0.93% 15.20%

500.55 496.8 505.8


1.05% 1.81%

160.25 152.15 148.1


-7.58% -2.66%

397.75 400.4 397.7


-0.01% -0.67%

4.49 3.67 3.49


-22.27% -4.90%

1.05 1.06 1.19


13.33% 12.26%

473.3 480.9 503.85


6.45% 4.77%

10.33 13.9 13.49


30.59% -2.95%

99.75 104.3 99.95


0.20% -4.17%

24.95 21.15 19.4


-22.24% -8.27%

9.42 9.36 8.99


-4.56% -3.95%

19.1 19.4 19.55


2.36% 0.77%

14.95 15.2 14.98


0.20% -1.45%
42.1 47 45.95
9.14% -2.23%

123.1 130.45 125.7


2.11% -3.64%

166.95 145.65 152


-8.95% 4.36%

82.05 78.45 80.45


-1.95% 2.55%

352.65 337.6 339.35


-3.77% 0.52%

170.4 149.75 156.55


-8.13% 4.54%

192.05 200.35 199.5


3.88% -0.42%

2657.2 2687 2,690.10


1.24% 0.12%

5.17 6.85 7.25


40.23% 5.84%

105.7 106.4 106.85


1.09% 0.42%

430.1 425 428.8


-0.30% 0.89%

1766 1776.4 1,735.50


-1.73% -2.30%

94.75 95.8 94.15


-0.63% -1.72%

203 287.15 285.55


40.67% -0.56%

28.95 29.65 28.15


-2.76% -5.06%

36.2 36 35.95
-0.69% -0.14%
40.85 39.65 38.65
-5.39% -2.52%

242.4 247.2 238.15


-1.75% -3.66%

29 28.4 29.05
0.17% 2.29%

117.9 116.25 122.45


3.86% 5.33%

558.1 545.7 537.7


-3.66% -1.47%

14.93 14.1 14.69


-1.61% 4.18%

4.54 4.6 4.14


-8.81% -10.00%

375.5 400 403.2


7.38% 0.80%

178.35 171.05 176.2


-1.21% 3.01%

419.4 422.8 441.25


5.21% 4.36%

5.2 5.05 4.76


-8.46% -5.74%

5.58 5.6 6.15


10.22% 9.82%

4.94 4.72 4.67


-5.47% -1.06%

8.4 7.97 7.58


-9.76% -4.89%

268.2 280.75 300.85


12.17% 7.16%

23 23.55 24.35
5.87% 3.40%

15.78 19.32 18.05


14.39% -6.57%

208.9 237.85 246.05


17.78% 3.45%

77.7 81.55 81.6


5.02% 0.06%

3.31 3.28 3.15


-4.83% -3.96%

29.5 32.85 28.75


-2.54% -12.48%

186.65 226.65 225.15


20.63% -0.66%

806.85 806.8 798.75


-1.00% -1.00%

3125.75 3037.3 3,100.75


-0.80% 2.09%

1.24 1.26 1.34


8.06% 6.35%

92.4 93.35 85.65


-7.31% -8.25%

2.41 2.42 2.3


-4.56% -4.96%
2006 2007
Gross Sales 271 307.09
Net Sales 244.8 276.3
Other Income 8.81 6.74
Value Of Output 252.06 270.01
Cost of Production 215.58 244.1
Selling Cost 8.17 9.87
PBIDT 33.65 35.87
PBDT 23.03 24.64
PBIT 25.73 27.25
PBT 15.11 16.02
PAT 12.73 12.77
CP 20.65 21.39
Revenue earnings in forex 78.63 93.13
Revenue expenses in forex 73.33 91.09
Capital earnings in forex 0 0
Capital expenses in forex 0.42 0.72
Book Value (Unit Curr) 74.53 84.07
Market Capitalisation 103.69 72.6
CEPS 17.43 18.1
(annualised) (Unit Curr)
EPS (annualised) (Unit Curr) 10.67 10.73
Dividend (annualised%) 15 12
Payout (%) 14.09 11.14
Cash Flow From Operating Activities 15.31 27.11
Cash Flow From Investing Activities -46.17 -24.17
Cash Flow From Financing Activities 28.3 -4.76

Rate of Growth (%)


ROG-Net Worth (%) 13.99 12.8
ROG-Capital Employed (%) 23.65 8.03
ROG-Gross Block (%) 33.4 5.95
ROG-Gross Sales (%) 5.52 13.32
ROG-Net Sales (%) 5.04 12.87
ROG-Cost of Production (%) 11.27 5.33
ROG-Total Assets (%) 20.45 0.9
ROG-PBIDT (%) -3.42 6.6
ROG-PBDT (%) -17.04 6.99
ROG-PBIT (%) -7.08 5.91
ROG-PBT (%) -26.69 6.02
ROG-PAT (%) -9.46 0.31
ROG-CP (%) -2.64 3.58
ROG-Revenue earnings in forex (%) 11.41 18.44
ROG-Revenue expenses in forex (%) 41.54 24.22
ROG-Market Capitalisation (%) -35.39 -29.98
RS IN CR
2008 2009 2010
335.85 409.69 496.95
310.73 376.51 471.42
1.84 0.17 0.45
319.97 369.56 467.66
273.86 304.87 388.46
8.96 10.75 13.5
40.89 58.98 74.04
27.46 34.19 57.34
31.26 47.94 60.52
17.83 23.15 43.82
13.07 15.05 26.1
22.7 26.09 39.62
109.3 139.36 152.79
84 96.82 116.22
0 0 0
0.06 1.34 0.63
93.13 102.46 120.15
61.42 44.5 123.7
19.08 21.77 32.98

10.85 12.34 21.43


18 30 50
16.6 24.29 24.1
30.95 60.86 43.47
-31.78 -6.45 -23.37
-0.68 -54.34 -19.15

10.77 10.22 17.39


7.98 -4.95 6.72
9.9 14.41 7.57
9.37 21.99 21.3
12.46 21.17 25.21
16.83 10.72 26.29
14.79 -2.14 5.72
13.99 44.24 25.53
11.44 24.51 67.71
14.72 53.36 26.24
11.3 29.84 89.29
2.35 15.15 73.42
6.12 14.93 51.86
17.36 27.5 9.64
-7.78 15.26 20.04
-15.4 -27.55 177.98
Particulars 31-Mar-06 31-Mar-07 31-Mar-08 31-Mar-09
Equity Capital 11.71 11.71 11.71 11.71
Reserves & sirplus 75.57 86.73 97.34 108.27
Less: misc exps 2.27 1.15 3.72 0.00
Net Worth 85.01 97.29 105.33 119.98
Borrowings
Long term 30.94 42.64 47.95 72.04
Short-Term-Bank 67.01 74.93 70.71 80.71
Short-Term-Others 84.13 74.99 86.51 25.73
Total Borrowings 182.09 192.56 205.17 178.48
TOTAL LIABILITIES 267.10 289.85 310.50 298.46

Gross Block 200.60 212.53 233.59 267.26


Less ; dep 50.95 62.36 74.47 87.88
Net Block 149.65 150.17 159.12 179.38
Capital WIP 0.16 13.91 14.86 0.8
Investments 20.40 21.35 33.53 21.38
Inventories 62.55 57.23 61.55 57.20
Sundry Debtors 69.73 73.72 97.01 106.33
Cash and Bank Balance 1.61 2.92 1.95 2.10
Total Current Assets 133.89 133.87 160.51 165.63
Loans and Advances 32.58 37.07 26.30 18.75
Fixed Deposits 4.51 1.37 0.87 0.76

Current assets , L & A 170.98 172.31 187.68 185.14


Current liabilities & provision 74.09 67.89 84.69 88.23

NWC 96.89 104.42 102.99 96.91


TOTAL ASSETS 267.10 289.85 310.50 298.46

SALES 271 307.09 335.85 409.69


COGS 237.35 271.22 294.96 350.71
RATIOS
CURRENT RATIO 2.31 2.54 2.22 2.10

INVENTORY TURNOVER 4.33 5.37 5.46 7.16

DEBTORS TURNOVER 3.89 4.17 3.46 3.85

PAYABLES TURN OVER 3.20 3.99 3.48 3.97


31-Mar-10
12.11
134.34
5.36
141.09

64.08
75.54
38.02
177.64
318.73

287.48
103.95
183.53
3.40
21.38
58.58
118.45
2.99
180.02
19.52
0.78

200.32
89.9

110.42
318.73

496.95
422.91

2.23 QUITE STABLE


INCREASING SO
COMPANY IS
8.48 MANAGING IT WELL
INCREASING SLIGHTLY
4.20 AND STABLE
REPAYING LIABILITIES
4.70 FREQUENTLY
FINANCIAL MODEL FOR AARTI DRUGS
PROFIT & LOSS STATEMENT
Particulars 31-Mar-01 31-Mar-02 31-Mar-03 31-Mar-04
Sales 149.92 174.61 192.14 237.70
COGS 129.23 149.29 167.73 211.07
Profitbef int & dep 20.68 25.32 24.42 26.64
Interest 8.31 8.66 5.50 3.86

Depreciation 3.89 4.38 5.10 5.72


pbt 8.48 12.29 13.82 17.06
tax rate 0.07 0.11 0.17 0.29
pat 7.91 10.93 11.44 12.08
Equity Capital 13.01 13.01 11.71 11.71

Dividend % 0.15 0.10 0.15 0.30


Payout(eq. cap*div %) 1.95 1.30 1.76 3.51

BALANCE SHEET
Particulars 31-Mar-01 31-Mar-02 31-Mar-03 31-Mar-04
Equity Capital 13.01 13.01 11.71 11.71
Reserves & sirplus 34.11 44.20 46.76 54.78
Less: misc exps 0.23 0.16 0.09 4.52
Net Worth 46.89 57.05 58.38 61.96
Borrowings
Long term 28.41 22.77 26.63 30.81
Short-Term-Bank 31.79 39.38 44.64 53.69
Short-Term-Others 4.00 6.93 12.28 22.31
Total Borrowings 64.19 69.08 83.55 106.81
TOTAL LIABILITIES 111.08 126.13 141.93 168.78

Gross Block 78.58 92.77 102.04 117.87

Less : depriciation 21.07 25.42 30.09 35.81


Net Block 57.51 67.34 71.95 82.06
Capital WIP 3.03 0.00 0.00 6.18

Investments 1.17 1.29 1.33 0.31


Current assets , L & A 80.45 87.43 106.99 149.26
Current liabilities & provision 31.07 29.92 34.48 61.53

NWC 49.38 57.50 72.50 87.73


TOTAL ASSETS 111.08 126.13 145.77 176.28

ROUGH SHEET

4 5 6 7
Term 3,081.23 4,680.16 3,094.12 4,263.63
Short-Term-Bank 5,368.61 4,524.31 6,701.47 7,493.42
Short-Term-Others 2,231.35 4,923.25 8,413.26 7,499.31
Total Borrowings 10,681.19 14,127.72 18,208.85
Gross Block 11,787.22 15,037.17 20,059.68
Less : Depreciation 3,581.36 4,262.30
Net Block 8,205.86 10,774.87 14,964.52
Captal Work In Progress 617.92
Investments 31.44 145.7 2,040.49 2,134.85
Current Assets, Loans and Advances
Current Liabilities 6,152.53 5,866.42 6,298.15
Net Working Capital 8,773.09 9,265.37
Book Value 52.92 62.5 72.6
Earning per share 10.32 12.01
31-Mar-05 31-Mar-06 31-Mar-07 31-Mar-08 31-Mar-09
265.27 271 307.09 335.85 409.69
231.65 237.35 271.22 294.96 350.71
33.62 33.65 35.87 40.89 58.98
5.86 10.62 11.23 13.43 24.79

7.15 7.92 8.62 9.63 11.04


20.61 15.11 16.02 17.83 23.15
0.32 0.16 0.20 0.27 0.35
14.06 12.73 12.77 13.07 15.05
11.71 11.71 11.71 11.71 11.71

0.30 0.15 0.12 0.18 0.30


3.51 1.76 1.4 2.11 3.51

31-Mar-05 31-Mar-06 31-Mar-07 31-Mar-08 31-Mar-09


11.71 11.71 11.71 11.71 11.71
64.86 75.57 86.73 97.34 108.27
3.39 2.27 1.15 3.72 0.00
73.18 85.01 97.29 105.33 119.98

46.80 30.94 42.64 47.95 72.04


45.24 67.01 74.93 70.71 80.71
49.23 84.13 74.99 86.51 25.73
141.28 182.09 192.56 205.17 178.48
214.45 267.10 289.85 310.50 298.46

150.37 200.60 212.53 233.59 267.26

42.62 50.95 62.36 74.47 87.88


107.75 149.65 150.17 159.12 179.38
22.60 0.16 13.91 14.86 0.8

1.46 20.40 21.35 33.53 21.38


151.32 170.98 172.31 187.68 185.14
58.66 74.09 67.89 84.69 88.23

92.65 96.89 104.42 102.99 96.91


224.46 267.10 289.85 310.50 298.46

8 9
4795.06 7,204.25
7070.5 8,070.95
8651.2 2,572.65
19,256.36 20516.76 17,847.85
21,253.39 23359.01 26,725.92
5,095.16 6,236.45 7446.69 8,788.25
15,016.94 15912.33 17,937.66
2,260.06 Nil 1375.2 1466.9 64.42
3352.82 2,137.85
14,925.62 15,131.79 17,098.48 17,231.02 18767.55
5,547.41 6626.63 7,076.76
10,800.32 11,683.60 12140.92 11,436.96
83.1 93.11 102.47
10.85 10.90 11.17 12.85
31-Mar-10 projection based on
496.95 CAGR FOR LAST TEN YEARS
422.91
74.04 CAGR FOR LAST TEN YEARS
16.70 LAST YR INTEREST/ AVG. DEBT FOR LAST 2 YRS

(LAST YR DEP./ LAST YR NET FIXED


13.52 ASSETS)* current yr net fixed assets
43.82
0.40 average of last five years
26.1
12.11 same as last year
as a growing company expected dividend
is expected to remain high and so taken as
0.50 last yr level of 50%
6.05

31-Mar-10 projection based on


12.11 same as last year
134.34 future PAT and last yr reserves
5.36 average of last TEN yrs
141.09

64.08
75.54
38.02
177.64 last two yrs total liabilities
318.73

287.48 CAGR FOR LAST TEN YEARS


accumulated depriciation and Gross assets
103.95 of last yr
183.53
3.40 USED AS PLUG
as per company's future plan 30, 35, and
21.38 45 cr in coming 3 years
200.32 same as last year
89.9 same as last year

110.42
318.73 net block + capital WIP+ Investments+

18,513.71
PROJECTED DATA
formula applied 31-Mar-11 31-Mar-12
0.14 567.73 648.59

0.15 85.31 98.3


0.0938 16.68 16.69

15.62 15.62 18.04


53.01 63.57
0.28 0.28 0.28
38.37 46.00
12.11 12.11

0.50 0.5
equity capital * dividend% 6.05 6.05

PROJECTED DATA
31-Mar-11 31-Mar-12
12.11 12.11
PAT this yr+ Reserves last yr-Div. paid this yr 166.66 206.61
2.09 2.09
equity cap+ reserves& surplus - misc exp 176.68 216.63

data not available


data not available
data not available
avg of last two yrs total liabilities 178.06 177.85
net worth + total borrowings = total liability 354.74 394.48

0.16 332.04 383.52


(accu. Dep last yr/gross fixed assets last
yr)* gross fixed assets this yr 120.06 138.68
211.98 244.84
2.34 4.22

30.00 35.00
200.32 200.32
89.9 89.9

110.42 110.42
net block + capital WIP+ Investments+ NWC 354.74 394.48
TED DATA
31-Mar-13
740.97

113.26
16.69

20.83
75.74
0.28
54.81
12.11

0.5
6.05

TED DATA
31-Mar-13
12.11
255.37
2.09
265.39

177.95
443.35

442.97

160.17
282.8
5.13

45.00
200.32
89.9

110.42
443.35
ROUGH SHEET

2006 2007
Gross Sales 271 307.09

Net Sales 244.8 276.3


Other Income 8.81 6.74

Value Of Output 252.06 270.01


Cost of Production 215.58 244.1

Selling Cost 8.17 9.87


PBIT 25.73 27.25

PBIDT 33.65 35.87


PBDT 23.03 24.64

PBT 15.11 16.02


PAT 12.73 12.77
CP 20.65 21.39
Revenue earnings in forex 78.63 93.13
Revenue expenses in forex 73.33 91.09
Capital earnings in forex 0 0
Capital expenses in forex 0.42 0.72
Book Value (Unit Curr) 74.53 84.07
Market Capitalisation 103.69 72.6

CEPS 17.43 18.1

(annualised) (Unit Curr)


EPS (annualised) (Unit Curr) 10.67 10.73
Dividend (annualised%) 15 12

Payout (%) 14.09 11.14


Cash Flow From Operating Activities
15.31 27.11
Cash Flow From Investing Activities
-46.17 -24.17

Cash Flow From Financing Activities


28.3 -4.76
ROG-Net Worth (%) 13.99 12.8
ROG-Capital Employed (%) 23.65 8.03
ROG-Gross Block (%) 33.4 5.95
ROG-Gross Sales (%) 5.52 13.32
ROG-Net Sales (%) 5.04 12.87
ROG-Cost of Production (%) 11.27 5.33
ROG-Total Assets (%) 20.45 0.9
ROG-PBIDT (%) -3.42 6.6
ROG-PBDT (%) -17.04 6.99
ROG-PBIT (%) -7.08 5.91
ROG-PBT (%) -26.69 6.02
ROG-PAT (%) -9.46 0.31
ROG-CP (%) -2.64 3.58
ROG-Revenue earnings in forex 11.41
(%) 18.44
ROG-Revenue expenses in forex 41.54
(%) 24.22
ROG-Market Capitalisation (%)
-35.39 -29.98
2008 2009 2010
335.85 409.69 496.95 ### ### ### ###

310.73 376.51 471.42 2,068.42 2,532.04 2,441.54 2,663.72


1.84 0.17 0.45 831.35 865.93 549.67 385.82

319.97 369.56 467.66 389.24 437.51 509.65 572.23


273.86 304.87 388.46 847.83 1,228.60 1,382.22 1,705.67

8.96 10.75 13.5 790.83 1,092.60 1,144.04 1,207.67


31.26 47.94 60.52 1,300.95 1,300.95 1,170.86 1,170.86

40.89 58.98 74.04 15 10 15 30


27.46 34.19 57.34 195.14 130.09 175.63 351.26

17.83 23.15 43.82 3,410.96 4,420.19 4,675.71 5,477.57


13.07 15.05 26.1 22.6 15.76 8.92 451.97
22.7 26.09 39.62 4,689.31 5,705.38 5,837.65 6,196.46
109.3 139.36 152.79
84 96.82 116.22 2,840.73 2,276.89 2,662.98 3,081.23
0 0 0 3,178.58 3,938.03 4,463.71 5,368.61
0.06 1.34 0.63 399.82 693.09 1,228.44 2,231.35
93.13 102.46 120.15 6,419.13 6,908.01 8,355.13 ###
61.42 44.5 123.7 7,857.90 9,276.53 ### ###

19.08 21.77 32.98 2,107.27 2,542.32 3,009.42 3,581.36

5,750.63 6,734.21 7,194.73 8,205.86


10.85 12.34 21.43 302.59 nil nil 617.92
18 30 50 116.99 128.87 132.55 31.44

16.6 24.29 24.1 8,044.98 8,742.51 ### ###


30.95 60.86 43.47 3,106.76 2,992.21 3,448.37 6,152.53
-31.78 -6.45 -23.37 4,938.22 5,750.30 7,250.15 8,773.09

-0.68 -54.34 -19.15 36.05 43.86 49.86 52.92


10.77 10.22 17.39
7.98 -4.95 6.72
9.9 14.41 7.57
9.37 21.99 21.3
12.46 21.17 25.21
16.83 10.72 26.29
14.79 -2.14 5.72
13.99 44.24 25.53
11.44 24.51 67.71
14.72 53.36 26.24
11.3 29.84 89.29
2.35 15.15 73.42
6.12 14.93 51.86
17.36 27.5 9.64
-7.78 15.26 20.04
-15.4 -27.55 177.98
###

3,362.00
586.08

714.7
2,061.22

1,406.22
1,170.86

30
351.26

6,486.07
339.32
7,317.61

4,680.16
4,524.31
4,923.25
###
###

4,262.30

###
2,260.06
145.7

###
5,866.42
9,265.37

62.5
cash flow statement projection

1) 2005 2006
A) Net Profit before Tax 15.11
B) depriciation 7.92
C) interest paid 10.62
NWC 92.65 96.89
D) LESS: Incremental WC 4.24
E) LESS: tax paid -2.38
OTHERS( LIKE exchange rate
loss/gain, inerest recvd, exp
F) amortized
Net Cash etc)
From Operating -12.15
Activities 14.88

2) Net Cash (used in)/from


investing Activities -45.75
Net Cash (used in)/from
3) Financing Activities 28.32
Net (decrease)/increase In
Cash and Cash
Opening Equivalents
Cash & Cash -2.56
Equivalents
Closing Cash & Cash 8.52
Equivalents 5.96
2007 2008 2009 2010 2011 E
16.02 17.83 23.15 43.82 53.01 FROM PROFORMA
8.62 9.63 11.04 13.52 15.62 FROM PROFORMA
11.23 13.43 24.79 16.70 16.7 FROM PROFORMA
104.42 102.99 96.91 110.42 110.42 FROM PROFORMA
7.53 -1.43 -6.08 13.51 0.00 FROM PROFORMA
-3.25 -4.76 -8.1 -17.72 -21.44 FROM PROFORMA
COMPANY'S CASH
FLOW
1.61 -12.42 3.89 0.66 -3.68 STATEMENT
26.70 25.14 60.85 43.47 60.21

-24.17 -31.78 -6.45 -23.37 -23.37 LAST YEAR FIGURE

-4.36 5.13 -54.33 -19.15 -19.15 LAST YEAR FIGURE

-1.83 -1.51 0.07 0.95 17.69


5.97 4.14 2.63 2.7 3.65
4.14 2.63 2.7 3.65 21.34
CASH FLOW STATEMENT
1) 2005 2006 2007 2008
A) Net Profit before Tax 15.11 16.02 17.83
B) depriciation 7.92 8.62 9.63
C) interest paid 10.62 11.23 13.43
NWC 92.65 96.89 104.42 102.99
D) LESS: Incremental WC 4.24 7.53 -1.43
E) LESS: tax paid -2.38 -3.25 -4.76
OTHERS( LIKE exchange rate
loss/gain, inerest recvd, exp
F) amortized
Net Cash etc)
From Operating -12.15 1.61 -12.42
Activities 14.88 26.70 25.14

2) Net Cash (used in)/from


investing Activities -45.75 -24.17 -31.78
Net Cash (used in)/from
3) Financing Activities 28.32 -4.36 5.13
Net (decrease)/increase In Cash
and CashCash
Opening Equivalents
& Cash -2.56 -1.83 -1.51
Equivalents 8.52 5.97 4.14
Closing Cash & Cash Equivalents 5.96 4.14 2.63
2009 2010 2011 E
23.15 43.82 53.01 FROM PROFORMA
11.04 13.52 15.62 FROM PROFORMA
24.79 16.70 16.7 FROM PROFORMA
96.91 110.42 110.42 FROM PROFORMA
-6.08 13.51 0.00 FROM PROFORMA
-8.1 -17.72 -21.44 FROM PROFORMA

3.89 0.66 -3.68 COMPANY'S CASH FLOW STATEMENT


60.85 43.47 60.21

-6.45 -23.37 -23.37 LAST YEAR FIGURE

-54.33 -19.15 -19.15 LAST YEAR FIGURE

0.07 0.95 17.69


2.63 2.7 3.65
2.7 3.65 21.34